- Details
- Description
Packaging Size:
60 capsules per HDPE container
Strength:
40 mg
Composition:
Mobocertinib succinate INN equivalent to mobocertinib 40 mg per capsule
Treatment:
Oral targeted anticancer medicine used for certain locally advanced or metastatic non-small-cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations.
Form:
Hard capsule
Brand:
Moboxen 40 mg
Quantity Unit:
Capsule
Manufacturer:
Everest Pharmaceuticals Ltd., Bangladesh
Moboxen 40 mg (Mobocertinib) is an oral targeted anticancer medicine manufactured by Everest Pharmaceuticals Ltd., Bangladesh. Each hard capsule contains mobocertinib 40 mg and is used for the treatment of certain adults with locally advanced or metastatic non-small-cell lung cancer (NSCLC) whose tumors have an EGFR exon 20 insertion mutation. Mobocertinib is an EGFR tyrosine kinase inhibitor that works by targeting abnormal EGFR signaling involved in cancer cell growth and survival. It is a prescription oncology medicine and should be used under the supervision of an appropriate healthcare professional.
Сопутствующие товары
